WEST PHARMACEUTICAL SERVICES INC
WSTLatest QuantConomy context for WST: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
WEST PHARMACEUTICAL SERVICES INC
West Pharmaceutical Services Inc is a leading global manufacturer of components and delivery systems for injectable drugs and healthcare products. Founded in 1923 and headquartered in Exton, Pennsylvania, the company designs and produces technologically advanced, high-quality integrated containment and delivery systems. Its product portfolio includes containment solutions, primary packaging, cartridge systems, prefillable systems, reconstitution and transfer systems, and specialty components. West Pharmaceutical Services also offers contract manufacturing and analytical lab services, serving major companies across the healthcare industry with a global distribution network spanning North and South America, Europe, Asia, and Australia. The company is committed to improving patient lives through its innovative solutions and aims to be the world leader in the integrated containment and delivery of injectable medicines.
- Symbol
- WST
- Name
- WEST PHARMACEUTICAL SERVICES INC
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq openfigi
Recent signals for WST
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Feb 12, 12:00 AM | WST filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| new position | bullish | 68 | Jun 23, 07:24 AM | MANUFACTURERS LIFE INSURANCE COMPANY, THE initiated new position in 0C1148 ($11.87M) - 47,358 shares ($11.87M) - [strong bullish signal] |
| executive change | neutral | 85 | Jun 1, 08:40 PM | WST filed 8-K: Regulation FD Disclosure, Director or Officer Changes - 2 material events - [very strong neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
INSTITUTIONAL signals are experimental: historical 13F coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| WST | NYSE | fmp | West Pharmaceutical Services, Inc. |
| WST | NYSE | alpaca | West Pharmaceutical Services, Inc. |
| WST | NYSE | alphavantage | West Pharmaceutical Services Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | HAUGEN JANET BRUTSCHEA | Insider | grant | 46 | $359.00 | $16,514 | 4 on EDGAR |
| May 12, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | exercise | 296 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query WST context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access